Search Results 141-150 of 16394 for Proto-oncogene
Multiplatform data helps Mayo Clinic specialists predict tumor behavior, including the risk of recurrence and likely response to treatment.
Cancer Biology. Sections. Overview · Faculty; Research Research. Focus Areas · Cancer Disparities · Cancer Stem Cells · Cancer Systems Biology · Oncogenic Gene ...
The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
This study aims to demonstrate acceptability and feasibility of the use of Distance Reiki therapy versus sham Reiki therapy among multiple myeloma patients.
Their efforts include the treatment of recurrent parathyroid tumors with percutaneous ethanol ablation, better detection of uncommon carcinoid and ...
Mayo Clinic scientists are working to improve the diagnosis and treatment of multiple endocrine neoplasia, type 2, also called MEN 2. Researchers study the ...
Obecabtagene autoleucel injection is an antineoplastic (cancer) medicine that is made from your own white blood cells, which have been modified to recognize and ...
Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.